Sage Capital Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-43,027
| Closed | -$1.77M | – | 110 |
|
|
2021
Q2 | $1.77M | Buy |
43,027
+4,082
| +10% | +$167K | 0.72% | 43 |
|
|
2021
Q1 | $1.41M | Buy |
38,945
+315
| +0.8% | +$11.4K | 0.63% | 44 |
|
|
2020
Q4 | $1.35M | Sell |
38,630
-1,828
| -5% | -$63.8K | 0.66% | 42 |
|
|
2020
Q3 | $1.41M | Buy |
40,458
+237
| +0.6% | +$8.25K | 0.86% | 35 |
|
|
2020
Q2 | $1.25M | Sell |
40,221
-140
| -0.3% | -$4.34K | 0.8% | 36 |
|
|
2020
Q1 | $1.25M | Buy |
40,361
+3,274
| +9% | +$101K | 1.02% | 31 |
|
|
2019
Q4 | $1.38M | Buy |
37,087
+900
| +2% | +$33.5K | 0.88% | 38 |
|
|
2019
Q3 | $1.23M | Buy |
36,187
+213
| +0.6% | +$7.26K | 0.93% | 37 |
|
|
2019
Q2 | $1.47M | Sell |
35,974
-412
| -1% | -$16.8K | 1.02% | 34 |
|
|
2019
Q1 | $1.47M | Sell |
36,386
-24,980
| -41% | -$1.01M | 0.94% | 33 |
|
|
2018
Q4 | $2.54M | Sell |
61,366
-16,251
| -21% | -$673K | 1.92% | 19 |
|
|
2018
Q3 | $3.25M | Buy |
77,617
+524
| +0.7% | +$21.9K | 2.03% | 19 |
|
|
2018
Q2 | $2.65M | Buy |
77,093
+325
| +0.4% | +$11.2K | 1.86% | 20 |
|
|
2018
Q1 | $2.59M | Buy |
76,768
+824
| +1% | +$27.7K | 1.83% | 21 |
|
|
2017
Q4 | $2.61M | Buy |
75,944
+433
| +0.6% | +$14.9K | 1.69% | 20 |
|
|
2017
Q3 | $2.56M | Buy |
75,511
+2,511
| +3% | +$85.1K | 1.8% | 20 |
|
|
2017
Q2 | $2.33M | Buy |
+73,000
| New | +$2.33M | 1.71% | 22 |
|